Gamma Knife Market - Forecast 2021 - 2026
Overview
Gamma Knife market size in 2019, is $236.5 million and is projected to reach revenue of $430.63 million by 2025. Gamma Knife is a non-invasive, high-precision radiation therapy. Highly focused radiation allows accurate radiosurgery to be done and does not damage the surrounding tissue. It has major application in oncology as it is used for treatment of malignant or benign tumors and also other medical conditions such as blood vessel malformations or brain disorders.
Key Takeaways
· The market is estimated to grow at a CAGR of 10.5% during the forecast period 2020-2025.
· The increased awareness about the safety of this procedure along with high success rate of this surgery and the rising incidence of disease are contributing to the market growth.
· Investment in technology improvement have led to better image resolutions and increased the accuracy of these machines. It is also likely to be used in the future for the treatment of other medical conditions.
Disease Indication - Segment Analysis
Based on the disease indication, the Gamma Knife market is dominated by the brain metastasis segment which is growing at a CAGR of 8.6%. Brain metastasis is a cancer that travels to the brain but originates from any other part of the body. This may enter deep in the brain and cannot be surgically treated. Thus gamma knife surgery is the most effective treatment for this.
Anatomy - Segment Analysis
Based on anatomy, the Gamma Knife market is categorized into head, neck and others. Head segment is said to hold major share in this market. This is due to the non-invasive and effective treatment of deep tumors in the head using this method. Alternatives such as neurosurgery pose a great risk to safety of patient. Thus gamma knife treatment is majorly done for deep tumors or cancer in the head.
Geography - Segment Analysis
North America accounts for 35% of the Gamma Knife market share in 2019. This is due to the prominence of this region in healthcare research and facilities. However, Asia Pacific segment is likely to be the fastest growing in the coming years with the increased adoption of gamma knife machines. These developing countries are improving their healthcare infrastructure and increasing R&D investments. It is also observed that the population here have an increasing awareness about Gamma Knife and its applications.
Drivers – Gamma Knife Market
· High demand for non-invasive surgery
With increasing awareness on the non-invasiveness of gamma knife surgeries, the demand for this procedure is rising. Also, the procedure has not many side effects unlike other neurosurgeries. Patients with deep brain tumors have increased safety with gamma radiosurgery rather than neurosurgery. This is because this method is highly accurate and the adjacent tissues do not have a risk of being damaged.
· Rising incidence of cancer and other neurological disorders
As per 2018 data from the WHO, the global cancer burden has risen to 18.1 million new cases and 9.6 million cancer related deaths. This rising incidence of cancer is mainly due to the changes in lifestyle. Increase in geriatric population affected by cancer is also driving the need for a non-invasive and precise treatment that has less side effects. As per the Neurological Alliance report 2019, 1 in 6 people have some neurological condition. Thus, gamma knife is useful in not just meningioma surgery or stereotactic radiosurgery but also for treating various neurological conditions.
Challenges – Gamma Knife Market
· High cost of machine and treatment
The gamma knife machine requires huge investments. Thus the availability of gamma knife treatment is restricted to only few medical centers. The treatment cost is also very high and some patients face a burden of treatment cost. It may also be required that multiple radiations are to be done for certain cases. This will further increase the cost of treatment. The treatment costs also depend upon severity of tumor, as well as the hospital and country of treatment.
Gamma Knife Industry Outlook
Various research activities and strategic alliances are the key strategies adopted by players in the Gamma Knife market. Gamma Knife top 10 companies are Elekta AB, Huiheng Medical, Varian Medical Systems, Accuray Incorporated, GE Healthcare, Philips Healthcare, Brainlab, American Radiosurgery Inc., Hitachi America, and Nordion Inc.
Gamma Knife Market Research Scope:
The base year of the study is 2019, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Gamma Knife Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats.
